BIO vs RM · rev $2.58B vs P/E 7.5, rev $588.5M
BIO (BIO) versus Regional Management Corp (RM) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Regional Management Corp (RM) is a credit services company listed on NYSE.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported RM revenue for 2024-12-31 was $588.5M. Net income was $41.2M. Revenue was up 6.7% from 2023-12-31 to 2024-12-31. RM currently screens at market cap $339.8M and trailing P/E 7.5.
BIO currently screens at market cap $0. RM currently screens at market cap $339.8M and trailing P/E 7.5.
Not investment advice. Open the BIO and RM stock pages for the full models.
Not investment advice.